Dentsply Sirona Reports Mixed Q2 2026 Results Amid Turnaround Efforts
Event summary
- Reported net sales of $898 million, down 4.1% YoY.
- Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%.
- Repurchased 1.3 million shares during the quarter.
- Reiterated 2026 outlook for net sales and adjusted EPS.
- Expanded partnership with Medline Sinclair in Canada.
The big picture
Dentsply Sirona's Q2 2026 results reflect ongoing challenges in its turnaround strategy, with mixed financial performance amid efforts to realign sales teams and strengthen distributor relationships. The company's focus on connected technology solutions and strategic partnerships aims to drive growth in a competitive dental products market.
What we're watching
- Execution Risk
- Whether the company's Return-to-Growth Action Plan can deliver sustained, profitable growth.
- Market Dynamics
- The impact of expanded partnerships on market penetration and revenue diversification.
- Financial Health
- How the company manages its debt levels and cash flow in the midst of restructuring efforts.